Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa C Lindesmith

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
NPJ Vaccines|December 15, 2020
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopesRaffaello Verardi, Lisa C Lindesmith, Yaroslav Tsybovsky, et al.
Immunity|June 20, 2019
Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus VaccinationLisa C Lindesmith, Jonathan R McDaniel, Anita Changela, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in miceDavid R Martinez, Alexandra Schäfer, Sarah R Leist, et al.
Science (New York, N.Y.)|July 2, 2021
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Sarah R Leist, et al.
Frontiers in Immunology|September 4, 2023
Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clustersCamilla A Strother, Paul D Brewer-Jensen, Sylvia Becker-Dreps, et al.
Science Translational Medicine|May 14, 2025
An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge studyBecca A Flitter, Joshua Gillard, Susan N Greco, et al.
Plos Pathogens|April 7, 2020
CD300lf is the primary physiologic receptor of murine norovirus but not human norovirusVincent R Graziano, Forrest C Walker, Elizabeth A Kennedy, et al.
NPJ Vaccines|October 1, 2024
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infectionElena N Atochina-Vasserman, Lisa C Lindesmith, Carmen Mirabelli, et al.
The Journal of Infectious Diseases|February 9, 2022
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model InoculumNadine Rouphael, Allison Beck, Amy E Kirby, et al.
Emerging Infectious Diseases|December 8, 2023
Emergence of Novel Norovirus GII.4 VariantPreeti Chhabra, Damien C Tully, Janet Mans, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
NPJ Vaccines|December 15, 2020
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopesRaffaello Verardi, Lisa C Lindesmith, Yaroslav Tsybovsky, et al.
Immunity|June 20, 2019
Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus VaccinationLisa C Lindesmith, Jonathan R McDaniel, Anita Changela, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in miceDavid R Martinez, Alexandra Schäfer, Sarah R Leist, et al.
Science (New York, N.Y.)|July 2, 2021
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Sarah R Leist, et al.
Frontiers in Immunology|September 4, 2023
Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clustersCamilla A Strother, Paul D Brewer-Jensen, Sylvia Becker-Dreps, et al.
Science Translational Medicine|May 14, 2025
An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge studyBecca A Flitter, Joshua Gillard, Susan N Greco, et al.
Plos Pathogens|April 7, 2020
CD300lf is the primary physiologic receptor of murine norovirus but not human norovirusVincent R Graziano, Forrest C Walker, Elizabeth A Kennedy, et al.
NPJ Vaccines|October 1, 2024
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infectionElena N Atochina-Vasserman, Lisa C Lindesmith, Carmen Mirabelli, et al.
The Journal of Infectious Diseases|February 9, 2022
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model InoculumNadine Rouphael, Allison Beck, Amy E Kirby, et al.
Emerging Infectious Diseases|December 8, 2023
Emergence of Novel Norovirus GII.4 VariantPreeti Chhabra, Damien C Tully, Janet Mans, et al.
Pageof 7